Free shipping on all orders over $ 500

AZD5718

Cat. No. M15061
AZD5718 Structure
Synonym:

Atuliflapon

Size Price Availability Quantity
5mg USD 285  USD285 In stock
10mg USD 420  USD420 In stock
25mg USD 760  USD760 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

AZD5718 (atuliflapon) is a 5-lox activating protein (FLAP) inhibitor that attenuates the 5-lipoxygenase pathway and reduces pro-inflammatory and vasoactive leukotriene (LT) production at an in vitro maximum 50% inhibitory concentration (IC50) of 39nM.

Chemical Information
Molecular Weight 446.5
Formula C24H26N6O3
CAS Number 2041075-86-7
Form Solid
Solubility (25°C) DMSO ≥ 60 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Hiddo J L Heerspink, et al. Kidney Int Rep. Design of FLAIR: a Phase 2b Study of the 5-Lipoxygenase Activating Protein Inhibitor AZD5718 in Patients With Proteinuric CKD

[2] Jane Knchel, et al. Clin Drug Investig. Pharmacokinetics, Pharmacodynamics, and Tolerability of AZD5718, an Oral 5-Lipoxygenase-Activating Protein (FLAP) Inhibitor, in Healthy Japanese Male Subjects

[3] Eva Prescott, et al. Contemp Clin Trials Commun. Design and rationale of FLAVOUR: A phase IIa efficacy study of the 5-lipoxygenase activating protein antagonist AZD5718 in patients with recent myocardial infarction

[4] Hans Ericsson, et al. Clin Pharmacol Drug Dev. Phase 1 Pharmacokinetic Study of AZD5718 in Healthy Volunteers: Effects of Coadministration With Rosuvastatin, Formulation and Food on Oral Bioavailability

[5] Hans Ericsson, et al. Clin Transl Sci. Initial Clinical Experience with AZD5718, a Novel Once Daily Oral 5-Lipoxygenase Activating Protein Inhibitor

Related Lipoxygenase Products
ALOX15-IN-2

ALOX15-IN-2 is a potent inhibitor of rabbit and human ALOX15 linoleate oxygenase activity, with IC50s of 1.55 and 2.79 μM for linoleic acid (LA) and arachidonic acid (AA), the immediate homologs of ALOX15, respectively.

Atractylochromene

Atractylochromene is a potent dual inhibitor of 5-LOX/COX-1 with IC50s of 0.6 and 3.3 μM, respectively.

5-LOX-IN-5

5-LOX-IN-5 is a 5-LOX inhibitor (IC50: 56 nM).

EP6

EP6 is a potent 5-Lipoxygenase (5-LO) inhibitor.

Patulitrin

Patulitrin has scavenging effect in the DPPH radical.

  Catalog
Abmole Inhibitor Catalog




Keywords: AZD5718, Atuliflapon supplier, Lipoxygenase, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.